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ABSTRACT
Objective: The incidence of small intestine cancer (SIC) is rising despite available preventive measures. Kaempferol and quercetin are a potential 
chemopreventive agent for SIC, but in vivo findings are inconclusive. We aim to study the effects of kaempferol and quercetin on colitis-associated 
small intestine carcinogenesis in mice.
Methods: Suppression effect was tested using mice divided into 6 groups of treatment, i.e.; normal (N) group, negative control (NC), leaf extract 
(medium dose [MD]) dose 12.5 and 25 mg/kg body weight (BW), leaf extract chitosan and nanoparticle of mahkota dewa (NPMD) dose 6.25 and 
12.5 mg/kg BW. Dextran sulfate sodium induction of 1% w/v was administered through drinking water for 6 weeks of treatment. The suppression 
effect was observed histopathologically by counting the mitotic cells and hyperplasia cells of the crypt of small intestine with hematoxylin-eosin 
staining.
Results: Mitosis cells mean of NC group was not significant difference either with MD 12.5 (p=0.394) or MD 6.5 (p=0.310). However, mitosis cell mean 
appears to be lower in the NPMD 12.5 (p=0.09) and NPMD 6.25 (p=0.05) groups than the NC group. There was a significant difference among the 
mean of hyperplasia NC group and MD and also NPMD group. Significant difference also can be showed between MD 12.5 and MD 25 (p=0.026), and 
between NPMD 6.25 and NPMD 12.5 (p=0.002), and between MD 12.5 and NPMD 12.5 (p=0.002).
Conclusion: Our results demonstrate suppression of hyperplasia small intestine by either nanoparticle or extract of Phaleria macrocarpa extracts. 
The suppression of mitosis was showed by administration of nanoparticle.
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INTRODUCTION
Small intestine cancer (SIC) is the third most common cancer in men 
and second most common cancer in women, representing 10% and 
9.1% of all cases, respectively. SIC accounts for 1.4 million new cancer 
cases in 2012, a majority of which (almost 55% cases) are diagnosed in 
the developed world [1,2]. SIC is preventable through routine screening 
for precancerous tumors with available methods. Nevertheless, the 
incidence of SIC is rising in most developing countries and some 
developed countries. This rise is thought to reflect an increase in the 
prevalence of SIC risk factors, which are largely related to dietary and 
lifestyle choices, including high intakes of red meat and processed foods, 
low fiber intake, low physical activity, obesity, smoking, and alcohol 
use [2,3]. For this reason, exploration of new preventive strategies, 
particularly chemoprevention, is gaining interest.
Phaleria macrocarpa belongs to the Moraceae family and widely grown 
in the islands of Java, Sumatra, Kalimantan, and Maluku. PM is also 
found in Malaysia and Thailand, and grow in a small extent in China. 
In Indonesia, PM is known as Mahkota Dewa for many are found grown 
well along in the South of Kalimantan. In its natural habitat, PM is an 
epiphytic grows on another plant or stick to either larger plants or 
on the rocks on which it depends for mechanical support but not for 
nutrients [4-6].
Numerous epidemiological studies have found an association between 
P. macrocarpa intake and better health outcomes, particularly a 
reduced risk of developing various cancers, including breast, lung, 
prostate, bladder, and endometrial cancer [7]. Recently, a systematic 
review and meta-analysis of 17 epidemiological studies have shown 
that P. macrocarpa intake has a protective effect against SIC, particularly 
in Asian populations. This makes P. macrocarpa an attractive candidate 
to explore for novel cancer-preventive agents [8].
One of the agents that had been identified in P. macrocarpa is 
kaempferol and quercetin, the 43 residues-long, 5.5 kDa subunit 
of the cotyledon-specific Gm2S-1 protein (2S albumin) that is also 
found in barley. Transient expression of kaempferol and quercetin 
leads to mitotic arrest and cell death in murine embryo fibroblasts, 
murine hepatoma cells, and human breast cancer cells. Suggests 
that kaempferol and quercetin have the potential to suppress both 
virally induced and chemically induced carcinogenesis. Kaempferol 
and quercetin promote apoptosis in fibroblasts expressing the viral 
oncogene E1A [9], suppresses small intestine formation in fibroblasts 
expressing the viral oncogene ras, and inhibits 7,12-dimethylbenz[a]
anthracene-induced skin papilloma development in mice. In addition 
to its antitumorigenic activity, kaempferol and quercetin also 
exhibit antioxidant, anti-inflammatory, and cholesterol-regulating 
properties [10-13].
In vitro studies have demonstrated the suppressive effects exerted by 
kaempferol and quercetin on small intestine carcinogenesis. Kaempferol 
and quercetin were found to block cell cycle at the G2 phase and 
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induce apoptosis in KM12L4 and HT-29 SIC cells and were otherwise 
cytotoxic to HCT-116 and RKO SIC cells. The antiproliferative and pro-
apoptotic effects of kaempferol and quercetin were shown to be dose-
dependent [14]. In vivo data have supported these findings, but are still 
inconclusive. Kaempferol and quercetin administered intraperitoneally 
were found to have inhibitory effects on SIC liver metastasis and to 
potentiate those of oxaliplatin. Inhibition of SIC liver metastasis by 
intraperitoneally administered kaempferol and quercetin has been 
replicated by another study. That study failed to demonstrate the 
inhibition of SIC liver metastasis with orally administered kaempferol 
and quercetin [8,9]. To date, only one study used colitis-associated SIC 
model. Mice given isoflavone-free P. macrocarpa protein concentrate 
as the sole source of protein have less severe crypt epithelial cell 
hyperplasia and dysplasia on induction of small intestine inflammation. 
The effect of administering varying doses of kaempferol and quercetin 
on colitis-associated small intestine carcinogenesis has not been 
explored. Here, we demonstrated inhibition of colitis-associated small 
intestine carcinogenesis in mice treated with kaempferol and quercetin 
in the form of P. macrocarpa extract [15].
METHODS
Animal
Male 12-week-old Swiss Webster mice with an average weight of 25 g 
were supplied by the Health Research and Development Agency of the 
Ministry of Health of the Republic of Indonesia. The mice were kept in 
independent ventilation cages (48 cm×35 cm×20 cm) with free access 
to food and water under controlled humidity (55±5%), light/dark cycle 
(12 h/12 h), and temperature (23°C±1°C). The mice were carefully 
examined to ensure that they are in healthy conditions and acclimatized 
for 1 week before any experimental procedure was performed. All 
protocols and surgical procedures were approved by the Animal Care 
and Use Committee of the Faculty of Medicine of the University of 
Indonesia.
Induction of small intestine with dextran sulfate sodium (DSS) and 
treatment of extract
Mice were randomized into the following 6 groups: Normal mice (N) 
group, which received no other treatment; negative control (NC) group, 
which received DSS 2% w/v (administered with drinking water starting 
at week 1 treatment then followed by administration of drinking water 
without DSS [16-21] for the next 1 week and repeated up to 3 DSS 
cycles); treatment groups medium dose (MD) 25 which received DSS 
2% w/v+Mahkota Dewa leaf extract 25 mg/kg body weight (BW) and 
MD 12.5 which received DSS 2% w/v+Mahkota Dewa leaf extract 25 
mg/kg BW; nanoparticle of mahkota dewa (NPMD) 12.5 and 6.25 which 
received DSS 2% b/v+Dewa Mahkota leaf extract in nano chitosan 
particle 12.5 and 6.25 mg/kg BW. All extracts were given orally starting 
at week 3 for 5 weeks. At the end of treatment, the mice were euthanized 
with ketamine for small intestine tissue collection and embedding into 
paraffin blocks [22,23].
Hematoxylin-eosin (HE) staining
Paraffin-embedded tissue samples are sliced into 4 µm-thick 
sections, which were then placed on an object glass for HE staining. 
The sections were deparaffinized with Xylol I, II, and III for 5 min 
each, then rehydrated with absolute alcohol, 96% alcohol, and 70% 
alcohol for 5 min each before being washed in running water for 
5 min. After that, the slides were placed in hematoxylin for 7 min, 
washed in running water for 10 min, placed in a saturated lithium 
carbonate solution for 1–2 min, and washed again in running water 
for 5 min. Slides with insufficient bluing were transferred back into 
hematoxylin for another 2 min then washed in running water. The 
slides were then placed in eosin for 1–2 min. After being stained, 
the slides were dehydrated with 70% alcohol, 80% alcohol, 96% 
alcohol, and absolute alcohol for 3 min each, then cleared with Xylol 
I, II, and III before being mounted with Entellan. Blinded histological 
examination was performed to evaluate crypt epithelial cell mitosis 
and hyperplasia.
Statistical analysis
All data are presented and were analyzed using Mann–Whitney U-test with 
SPSS 20.0 statistical package. p<0.05 was considered statistically significant.
RESULTS
Effect of P. macrocarpa extract administration on mitosis
The effect of P. macrocarpa extract administration on crypt epithelial 
cell mitosis after induction of DSS is shown in Fig. 1. Mann–Whitney 
U-test showed that mitosis cells mean of NC group was not significant 
difference either with MD 12.5 (p=0.394) or MD 6.5 (p=0.310). However, 
mitosis cell mean appears to be lower in the NPMD 12.5 (p=0.09) and 
NPMD 6.25 (p=0.05) groups than the NC group. The NPMD 12.5 has the 
lower mitosis cell mean than MD 12.5 group (p=0.026).
Effect of P. macrocarpa extract administration on the hyperplasia
The effect of P. macrocarpa extract administration on the mean of crypt 
epithelial cell hyperplasia after induction of DSS is shown in Fig. 2. The mean 
of hyperplasia cells is also shown to be lower in treatment groups than the 
NC group. There was significant difference among mean of hyperplasia 
NC group and MD and also NPMD group. Significant difference also can be 
showed between MD 12.5 and MD 25 (p=0.026), and between NPMD 6.25 
and NPMD 12.5 (p=0.002), and between MD 12.5 and NPMD 12.5 (p=0.002).
DISCUSSION
This study uses the colitis-associated SIC mice model. DSS induces 
chronic inflammation, involving such molecular processes as 
Fig. 1: Mean mitosis cells of mice crypt epithelial cells after 
induction of dextran sulfate sodium
Fig. 2: Mean hyperplasia score of mice crypt epithelial cells after 
induction of dextran sulfate sodium
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overproduction of reactive oxygen and nitrogen species, upregulation 
of cytokines and enzymes of arachidonic acid biosynthetic pathway, and 
dysfunction of the intestinal immune system. Any or all of these events 
may contribute to small intestine inflammation [24], which is observed 
as increased mitosis and hyperplasia of crypt epithelial cells.
Our results support the hypothesis that P. macrocarpa provides 
protection against colitis-associated SIC in male Swiss Webster 
mice. Daily administration of P. macrocarpa extract at a dose of 12.5 
or 25 mg/kg BW after small intestine induction with DSS did not 
suppress mitosis, but it showed suppress hyperplasia of crypt epithelial 
cells. It was not similar to the administration of (NPMD). DSS-induced 
crypt epithelial cell hyperplasia and mitosis were suppressed by daily 
administration of NPMD. This can potentially be explained by the 
higher doses of kaempferol and quercetin in those groups with greater 
reduction in hyperplasia. It is unclear why suppression of mitosis does 
not follow this trend. As hyperplasia is the combined effect of increased 
mitosis and decreased apoptosis, it is possible that the reduction in 
hyperplasia observed is contributed primarily by an increase in crypt 
epithelial cell apoptosis and that suppression of mitosis is simply less 
pronounced.
P. macrocarpa has long been suspected to lower cancer risk, and many 
substances with potential antitumorigenic properties have been 
identified in P. macrocarpa [25].
Kaempferol and quercetin have been identified recently as a novel 
chemopreventive agent in P. macrocarpa.
To the best of our knowledge, ours is the first study to demonstrate 
suppression of mitosis and hyperplasia in colitis-associated SIC mice 
model by kaempferol and quercetin in P. macrocarpa extract. However, 
the kaempferol and quercetin extract that we used was not highly 
purified. Therefore, the possibility of other substances affecting mitosis 
and hyperplasia cannot be ruled out. Nevertheless, our observations are 
most probably attributable to kaempferol and quercetin as a previously 
identified chemopreventive agent with demonstrated suppressive 
effects on carcinogenesis in vitro.
CONCLUSION
We have demonstrated that the administration of P. macrocarpa extract 
and its nanoparticle protects mice against colitis small intestine in mice. 
The protective effects were observed as suppression of mitosis and 
hyperplasia in crypt epithelial cells.
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